The vector of anti-CD1a-lysophosphatidylcholine T cell receptor (TCR) is constructed for the engineering of T cell to target CD1a-lysophosphatidylcholine. The T cells are genetically modified through transduction with a lentiviral vector expressing CD1a-lysophosphatidylcholine-specific T cell receptor. And the vector product was designed for the treatment of Cancer and autoimmune diseases.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved